Pages that link to "Q43603007"
Jump to navigation
Jump to search
The following pages link to Response of experimental retinal neovascularization to thiazolidinediones (Q43603007):
Displaying 44 items.
- Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases (Q27022548) (← links)
- Medical management of diabetic retinopathy (Q33204062) (← links)
- alphaB-crystallin regulation of angiogenesis by modulation of VEGF. (Q33519880) (← links)
- Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes. (Q33692555) (← links)
- Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology. (Q33867982) (← links)
- Is rosiglitazone use associated with an increase in intensive eye treatment in diabetic patients? A community based study. (Q33957134) (← links)
- Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy (Q34287296) (← links)
- Molecular Implications of the PPARs in the Diabetic Eye. (Q34863935) (← links)
- Ophthalmic drug discovery (Q35140846) (← links)
- Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence (Q35162317) (← links)
- Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model (Q35221114) (← links)
- Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents (Q35761726) (← links)
- Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity. (Q36068458) (← links)
- Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism (Q36555556) (← links)
- PPARgamma Agonists: Potential as Therapeutics for Neovascular Retinopathies (Q36676571) (← links)
- Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARgamma Dependent and Independent Mechanisms (Q36890814) (← links)
- 5-Lipoxygenase Metabolite 4-HDHA Is a Mediator of the Antiangiogenic Effect of ω-3 Polyunsaturated Fatty Acids (Q37011389) (← links)
- Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway (Q37141708) (← links)
- The possible role of peroxisome proliferator-activated receptor gamma in heart failure. (Q37277818) (← links)
- Autophagy in Diabetic Retinopathy (Q37677015) (← links)
- Pioglitazone inhibits HIF-1α-dependent angiogenesis in rats by paracrine and direct effects on endothelial cells (Q37707352) (← links)
- Caveolins and caveolae in ocular physiology and pathophysiology. (Q38963501) (← links)
- Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation (Q41570973) (← links)
- Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases (Q41625930) (← links)
- PPAR-gamma, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches (Q41938308) (← links)
- Anti-angiogenic action of PPARγ ligand in human umbilical vein endothelial cells is mediated by PTEN upregulation and VEGFR-2 downregulation (Q42491731) (← links)
- Effects of 15d-PGJ(2) on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cells (Q42530171) (← links)
- Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis (Q42574886) (← links)
- WY-14 643, a Selective PPARα Agonist, Induces Proinflammatory and Proangiogenic Responses in Human Ocular Cells (Q42872505) (← links)
- Peroxisome proliferator-activated receptor ligands as antiatherogenic agents: panacea or another Pandora's box? (Q43986735) (← links)
- Pioglitazone reduces monocyte adhesion to vascular endothelium under flow by modulating RhoA GTPase and focal adhesion kinase (Q44628017) (← links)
- Peroxisome proliferator-activated receptor gamma mediated inhibition of plasminogen activator inhibitor type 1 production and proliferation of human umbilical vein endothelial cells (Q44633767) (← links)
- Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats (Q44642285) (← links)
- Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide (Q44744482) (← links)
- Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism (Q45281571) (← links)
- Dual Peroxisome Proliferator-Activated Receptor-alpha/gamma Agonists : In the Treatment of Type 2 Diabetes Mellitus and the Metabolic Syndrome. (Q45938691) (← links)
- PPAR gamma: a novel pharmacological target against retinal and choroidal neovascularization (Q46481660) (← links)
- Rosiglitazone-associated pseudotumour cerebri (Q46848294) (← links)
- Antiangiogenic effect of rosiglitazone is mediated via peroxisome proliferator-activated receptor gamma-activated maxi-K channel opening in human umbilical vein endothelial cells (Q46983586) (← links)
- Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders (Q48550782) (← links)
- Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease. (Q53279548) (← links)
- Effect of thiazolidinedione on the proliferation of bovine retinal endothelial cells stimulated by vascular endothelial cell growth factor. (Q53571642) (← links)
- Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma (Q81554853) (← links)
- Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Q92406505) (← links)